MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy.

Modern three-dimentional radiotherapy is based upon CT. For rectal cancer, this relies upon target definition on CT, which is not the optimal imaging modality. The major limitation of CT is its low inherent contrast resolution. Targets defined by MRI could facilitate smaller, more accurate, tumour volumes than CT. Our study reviewed imaging and planning data for 10 patients with locally advanced low rectal cancer (defined as < 6 cm from the anal verge on digital examination). Tumour volume and location were compared for sagittal pre-treatment MRI and planning CT. CT consistently overestimated all tumour radiological parameters. Estimates of tumour volume, tumour length and height of proximal tumour from the anal verge were larger on planning CT than on MRI (p < 0.05). Tumour volumes defined on MRI are smaller, shorter and more distal from the anal sphincter than CT-based volumes. For radiotherapy planning, this may result in smaller treatment volumes, which could lead to a reduction in dose to organs at risk and facilitate dose escalation.

[1]  D. Rajasekar,et al.  Multimodality image fusion in dose escalation studies of brain tumors , 2000, Journal of applied clinical medical physics.

[2]  R. Newcombe,et al.  Rectal carcinoma: thin-section MR imaging for staging in 28 patients. , 1999, Radiology.

[3]  H. von der Maase,et al.  Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  P. D. Peppercorn,et al.  Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study , 2006, BMJ : British Medical Journal.

[5]  B. Lind,et al.  Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. , 2005, International journal of radiation oncology, biology, physics.

[6]  A. Mellgren,et al.  Long-Term Effect of Preoperative Radiation Therapy on Anorectal Function , 2006, Diseases of the colon and rectum.

[7]  A. Norman,et al.  Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Steve Webb,et al.  Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  L. Blomqvist,et al.  Rectal adenocarcinoma: assessment of tumour involvement of the lateral resection margin by MRI of resected specimen. , 1999, The British journal of radiology.

[10]  B. O'neill,et al.  Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. , 2007, The Lancet. Oncology.

[11]  R G Newcombe,et al.  Preoperative assessment of prognostic factors in rectal cancer using high‐resolution magnetic resonance imaging , 2003, The British journal of surgery.

[12]  M. Sydes,et al.  The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397). , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  W. Regine,et al.  Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. , 2000, International journal of radiation oncology, biology, physics.

[14]  P. Adeleine,et al.  Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. V. D. van de Velde,et al.  Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Willett,et al.  Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.